FindTrial
Sign In

Observation of effect of dexmedetomidine when given intravenously to the pediatric patients undergoing levobupivacaine spinal anaesthesia.

Effect of i.v.dexmedetomidine on levobupivacaine spinal anaesthesia in pediatric patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/12/010744
Enrollment
70
Registered
2017-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- good health.

Interventions

Intervention1: dexmedetomidine: effect of i.v. dexmedetomidine either prolong or not spinal levobupivacaine effect..and what are other others effects of i.v. dexmedetomidine.

Sponsors

Department of anaesthesia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) class-1 and class-2 patients 2) lower abdominal surgery 3) 2 year to 12 year age

Exclusion criteria

Exclusion criteria: 1) patients refusal. 2) contraindication for spinal anaesthesia

Design outcomes

Primary

MeasureTime frame
Intravenous dexmedetomidine prolong the effect of bupivacaine spinal anaesthesiaTimepoint: end of clinical trial—

Secondary

MeasureTime frame
provide haemodynamic stability. provide good intraoperative sedation and pain free period during operation and postoperative periodTimepoint: end of clinical trial—

Countries

India

Contacts

Public Contactvaibhav sonavia

goverment medical college

Abhishek6777777@gmail.com9099934244

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026